<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Transbound Emerg Dis</journal-id><journal-id journal-id-type="iso-abbrev">Transbound Emerg Dis</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1865-1682</journal-id><journal-id journal-id-type="publisher-id">TBED</journal-id><journal-title-group><journal-title>Transboundary and Emerging Diseases</journal-title></journal-title-group><issn pub-type="ppub">1865-1674</issn><issn pub-type="epub">1865-1682</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7362058</article-id><article-id pub-id-type="doi">10.1111/tbed.13710</article-id><article-id pub-id-type="publisher-id">TBED13710</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Reviews</subject></subj-group></article-categories><title-group><article-title>COVID&#x02010;19 drug repurposing: Summary statistics on current clinical trials and promising untested candidates</article-title></title-group><contrib-group><contrib id="tbed13710-cr-0001" contrib-type="author" corresp="yes"><name><surname>Ulm</surname><given-names>J. Wes</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9224-4963</contrib-id><xref ref-type="aff" rid="tbed13710-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="tbed13710-aff-0002">
<sup>2</sup>
</xref><address><email>wes_ulm@post.harvard.edu</email></address></contrib><contrib id="tbed13710-cr-0002" contrib-type="author"><name><surname>Nelson</surname><given-names>Stanley F.</given-names></name><xref ref-type="aff" rid="tbed13710-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="tbed13710-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Human Genetics</named-content>
<named-content content-type="organisation-division">David Geffen School of Medicine</named-content>
<institution>University of California</institution>
<city>Los Angeles</city>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff><aff id="tbed13710-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Medical Genetics</named-content>
<institution>University of Pittsburgh School of Medicine</institution>
<city>Pittsburgh</city>
<named-content content-type="country-part">PA</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Corresponding author<break/>
Email id: <email>wes_ulm@post.harvard.edu</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>7</month><year>2020</year></pub-date><elocation-id>10.1111/tbed.13710</elocation-id><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2020 Blackwell Verlag GmbH <copyright-statement>--><copyright-statement content-type="article-copyright">This article is protected by copyright. All rights reserved.</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:TBED-9999-na.pdf"/><abstract id="tbed13710-abs-0001"><title>Summary</title><p>Repurposing of existing antiviral drugs, immunological modulators, and supportive therapies represents a promising path toward rapidly developing new control strategies to mitigate the devastating public health consequences of the COVID&#x02010;19 pandemic. A comprehensive text&#x02010;mining and manual curation approach was used to comb and summarize the most pertinent information from existing clinical trials and previous efforts to develop therapies against related betacoronaviruses, particularly SARS and MERS. In contrast to drugs in current trials, which have been derived overwhelmingly from studies on taxonomically unrelated RNA viruses, a number of untested small molecule antivirals had previously demonstrated remarkable in vitro specificity for SARS&#x02010;CoV or MERS&#x02010;CoV, with high selectivity indices, EC<sub>50</sub>, and/or IC<sub>50</sub>. Due to the rapid containment of the prior epidemics, however, these were generally not followed up with in vivo animal studies or clinical investigations, and thus largely overlooked as treatment prospects in the current COVID&#x02010;19 trials. This brief review summarizes and tabulates core information on recent or ongoing drug repurposing&#x02010;focused clinical trials, while detailing the most promising untested candidates with prior documented success against the etiologic agents of SARS and/or MERS.</p></abstract><kwd-group><kwd id="tbed13710-kwd-0001">antiviral agents</kwd><kwd id="tbed13710-kwd-0002">COVID&#x02010;19</kwd><kwd id="tbed13710-kwd-0003">data mining</kwd><kwd id="tbed13710-kwd-0004">drug repositioning</kwd><kwd id="tbed13710-kwd-0005">pandemics</kwd><kwd id="tbed13710-kwd-0006">SARS</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><page-count count="13"/><word-count count="353"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>accepted-manuscript</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.5 mode:remove_FC converted:15.07.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="tbed13710-ntgp-0001"><fn id="tbed13710-note-0001"><p>This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/tbed.13710</p></fn></fn-group></notes></front></article>